Exhaled nitric oxide and pulmonary complications after paediatric stem cell transplantation.

European Journal of Pediatrics
T FazekasC Peters

Abstract

Pulmonary complications are major causes of morbidity and mortality after haematopoietic stem cell transplantation (HSCT). We hypothesise that elevated exhaled nitric oxide (FeNO) levels early after HSCT in children are predictive for pulmonary complications. The present prospective study included 30 children (age, 4-18 years) before HSCT. FeNO levels were evaluated 10 days before transplant, at day 0, day +28 and day +60 after HSCT. During the follow-up period until day +100, pulmonary complications and lung function were assessed. Before HSCT, the mean FeNO levels were comparable in children with or without post-transplant pulmonary complications. However, they differed at day 0 and day +28 with a mean of 7 (±1.95) and 13 (±3.44) ppb at day 0 and a mean of 13 (±3.44) and 14 (±3.57) ppb at day +28, respectively. Children with pulmonary complications after day +28 have higher mean FeNO levels 28 days after HSCT than children without later pulmonary complications. Therefore, FeNO could be an important diagnostic tool for hyperinflammatory response in bronchial epithelium after paediatric HSCT.

References

Aug 1, 1992·The Journal of Clinical Investigation·J M LangrehrR A Hoffman
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroG Chaudhuri
Apr 1, 1996·Chest·A O SoubaniP M Hassoun
Aug 2, 2002·Postgraduate Medical Journal·I Khurshid, L C Anderson
Aug 9, 2002·The European Respiratory Journal·E BaraldiUNKNOWN European Respiratory Society/American Thoracic Society (ERS/ATS) Task Force
Apr 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN European Respiratory Society
May 20, 2005·American Journal of Respiratory and Critical Care Medicine·Andrew D SmithD Robin Taylor
Jun 9, 2005·The Journal of Allergy and Clinical Immunology·Frederik BuchvaldHans Bisgaard
Nov 3, 2005·The European Respiratory Journal·R PellegrinoJ Wanger
Dec 13, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Alexandra H FilipovichMary E D Flowers
Mar 25, 2006·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society Workshop
Feb 16, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Susanne Matthes-MartinThomas Klingebiel
Nov 23, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·C NeurohrUNKNOWN Munich Lung Transplant Group

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
PCR

Software Mentioned

PC
SPSS

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Journal of Investigational Allergology & Clinical Immunology
I Agache, C Ciobanu
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
Rebecca Cutts, Steve Turner
Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)
S Pérez TarazonaJ Talens Gandía
© 2022 Meta ULC. All rights reserved